Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000255829 | SCV000322477 | pathogenic | not provided | 2022-02-27 | criteria provided, single submitter | clinical testing | Canonical splice site variant in a gene for which loss-of-function is a known mechanism of disease. Results in aberrant splicing in which 82 bp intronic sequences are retained through the use of a cryptic splice donor site within intron 10, resulting in a premature stop codon (Ohba et al., 2014).; Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 26790960, 26481852, 28711740, 25533962, 28135719, 28191890, 30842224, 24621584, 23176820, 31293896, 31505688, 33504798, 33037762, 31038196) |
Institute Of Human Genetics Munich, |
RCV000578469 | SCV000680434 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2017-10-13 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000578469 | SCV000817297 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2024-01-22 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 10 of the WDR45 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in WDR45 are known to be pathogenic (PMID: 23176820, 24368176, 24621584, 25744623, 26790960, 27030146, 27652284, 28554332). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with betapropeller protein-associated neurodegeneration and Rett-like syndrome with childhood iron deposition in brain (PMID: 23176820, 24621584, 28711740). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 265508). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV000578469 | SCV001428545 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2023-10-13 | criteria provided, single submitter | clinical testing | Criteria applied: PVS1,PM2_SUP_STR,PS4_MOD |
3billion | RCV000578469 | SCV002012058 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2021-10-02 | criteria provided, single submitter | clinical testing | Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). The variant has been observed in at least two similarly affected unrelated individuals (PMID: 28711740, 24621584, PS4_M).It is not observed in the gnomAD v2.1.1 dataset (PM2). The variant was observed as assumed (i.e. paternity and maternity not confirmed) de novoo (3billion dataset, PM6). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. |
Revvity Omics, |
RCV000578469 | SCV002020899 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2021-02-24 | criteria provided, single submitter | clinical testing | |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV000578469 | SCV002499092 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2022-03-02 | criteria provided, single submitter | clinical testing | PVS1, PS2_Very Strong, PM2 |
Ce |
RCV000255829 | SCV002822025 | pathogenic | not provided | 2022-11-01 | criteria provided, single submitter | clinical testing | WDR45: PVS1, PS2, PM2 |
Genome |
RCV000845069 | SCV000986910 | not provided | Neurodegeneration with brain iron accumulation | no assertion provided | phenotyping only | Variant interpretted as pathogenic and reported on 04/11/2016 by GTR ID 26957. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Pediatric Genetics Clinic, |
RCV000578469 | SCV001712253 | pathogenic | Neurodegeneration with brain iron accumulation 5 | 2021-05-13 | no assertion criteria provided | clinical testing | |
Génétique des Maladies du Développement, |
RCV000578469 | SCV002097051 | pathogenic | Neurodegeneration with brain iron accumulation 5 | no assertion criteria provided | clinical testing |